Redeye: Saniona Q1 2023 - On the right path
Redeye returns with an updated view of Saniona following the Q1 report and recent events in the company. We reiterate our stance that 2023 will be an important year for the company – most notably to deliver on its goal of non-dilutive incomes.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/